Migraine Therapeutics Market Size to Surpass US$ 11.43 billion by 2031 - Growth Plus Reports Pune, Dec. 19, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Migraine Therapeutics Market is expected to clock US$ 11.43 billion by 2031 and to...

Migraine Therapeutics Market Report (2023 to 2031) - Eli Lilly and Company, Allergan Inc., Pfizer Inc., GSK plc. and Merck & Co. Inc. Newark, New Castle, USA, May 31, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global migraine therapeutics market was conducted by Growth Plus Reports in 2022 and was valued at US$ 5.13...